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Girdin, an actin-binding Akt substrate, regulates actin reconstruction and Akt-dependent 
cell migration in fibroblasts and a human breast cancer cell line. We examined whether Girdin was 
also involved in the migration of esophageal squamous cell carcinoma (ESCC) cells. First, 
immunofluorescent staining and migration assays were performed, using KYSE cell lines, to 
examine whether Girdin was involved in the migration of ESCC cells. Upon EGF stimulation, 
Girdin colocalized with filamentous actin in the lamellipodia as determined by immunofluorescent 
staining. In migration assays, cell migration was significantly reduced in KYSE cell lines transfected 
with Girdin siRNA compared with the negative control. Next, we examined the relationship between 
Girdin expression and clinical data, using specimens resected from ESCC patients. In 
immunohistochemical analyses using specimens resected from ESCC patients, overall survival was 
significantly longer in cases showing higher Girdin expression than in cases with lower Girdin 
expression. Taken together, it appears that Girdin is involved in the migration of ESCC cells. The 
level of Girdin expression correlated inversely with the survival of ESCC patients.  Therefore, in 
ESCC, Girdin is expected to be a prognostic marker and to be a therapeutic target, as well.  
 
